Question Title

* 1. Do you work with children or adolescents who have a stated gender identity that does not match their sex, who have or have signs of gender dysphoria or are gender questioning?  *If “yes” please continue through the survey, if “no” please skip ahead to the end of the survey to leave your comments. Thank you.

Question Title

* 2. In which Canadian province or territory do you currently practice your Mental Health profession?

Question Title

* 3. What is your profession within the Mental Health Care Community?

Question Title

* 4. In your province, are you required by law or policy to affirm the stated gender identity of the children and adolescents you work with?

Question Title

* 5. If you answered yes to question 4, do you agree with the law/policy that requires you to affirm the stated gender identities of the children and adolescents you work with?

Question Title

* 6. If you answered no to question 5, have you taken steps to push back or voice your concerns against these laws/policies?

Question Title

* 7. Are you licensed or permitted within your professional designation to prescribe gender affirming medications to the children or adolescents you work with (ie. GnRH Agonists, also known as Puberty Blockers; Testosterone or Estrogen injections)?

Question Title

* 8. Are you licensed or permitted within your professional designation to make written recommendations for gender affirming surgeries (ie. bilateral mastectomy; vaginoplasty; phalloplasty) for the children or adolescents you work with?

Question Title

* 9. Approximately how many of the children and adolescents that you work with have a stated gender identity that does not match their sex, have or have signs of gender dysphoria, or are gender questioning?

Question Title

* 10. Based on your answer from question 9, approximately how many of those children and adolescents have you prescribed gender affirming medications for (ie. GnRH Agonists, also known as Puberty Blockers; Testosterone or Estrogen injections)?

Question Title

* 11. Again, based on your answer from question 9, approximately how many of those children and adolescents have you written recommendations for gender affirming surgeries for (ie. bilateral mastectomy; vaginoplasty; phalloplasty)?

Question Title

* 12. Once again, based on your answer to question 9, approximately how many of those children and adolescents have other diagnosed or suspected mental health concerns or conditions?

Question Title

* 13. Based on your answer to question 12, please check the other diagnosed or suspected mental health concerns or conditions pertaining to those children and adolescents.

Question Title

* 14. For the children and adolescents you work with how effective has gender affirming mental health care been in improving their mental health?

Question Title

* 15. For the children and adolescents you work with how effective have gender affirming medications (ie. GnRH Agonists, also known as Puberty Blockers; Testosterone or Estrogen injections) been in improving their mental health?

Question Title

* 16. For the children and adolescents you work with how effective have gender affirming surgeries (ie. bilateral mastectomy; vaginoplasty; phalloplasty) been in improving their mental health?

Question Title

* 17. For the children and adolescents you work with, approximately how long after they begin to receive gender affirming medications (ie. GnRH Agonists, also known as Puberty Blockers; Testosterone or Estrogen injections) do you typically have follow up contact?

Question Title

* 18. For the children and adolescents you work with, approximately how long after they have had gender affirming surgery (ie. bilateral mastectomy; vaginoplasty; phalloplasty) do you typically have follow up contact?

Question Title

* 19. Presently, how comfortable are you in your profession in regard to Gender Affirming Care in Canada?

Question Title

* 20. As a mental health care professional, would you welcome a systematic review of the Gender Affirming Care model currently used in Canada?

Question Title

* 21. Please use this space to add your comments.

T